Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Replacement: Director/PDMR Shareholding

22 Apr 2026 13:00

RNS Number : 5259B
IDOX PLC
22 April 2026
 

The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 22 April 2026 at 11:24 under RNS No 5164B. Removal of square brackets "[23]". All other details remain unchanged. The full amended text is shown below.

22 April 2026

Idox plc 

("Idox", "the Company" or "the Group")

Director/PDMR Shareholding and Total Voting Rights

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset intensive sectors, announces that, on 22 April 2026, it has allotted and issued new ordinary shares of 1 pence each ("Ordinary Shares") pursuant to the exercise of options by four of its PDMRs, as detailed in the table below. The exercise of the options occurred immediately following the recommended cash offer by Frankel UK Bidco Limited, a company indirectly owned by Long Path Partners, to acquire the entire issued and to be issued share capital of Idox and which announced on 28 October 2025 (the "Offer") becoming unconditional.

The Company also announces that, on the same day, the PDMRs noted in the table below each unconditionally agreed to sell the Ordinary Shares (including, where relevant, the Ordinary Shares acquired on exercise of the options) at a price of 71.5p pence per share under the terms of the Offer. The transfer of the Ordinary Shares to Frankel UK Bidco Limited will take place shortly after the date on which the Offer become unconditional pursuant to the terms of the Offer.

PDMR

Role

Number of Ordinary Shares acquired following exercise of options

Exercise price per Ordinary Share

Number of Ordinary Shares sold (comprising both Ordinary Shares acquired following exercise of options and other Ordinary Shares held by the PDMR)

David Meaden

CEO

1,837,455

0p

3,290,842

Anoop Kang

CFO

1,440,477

0p

1,458,699

Jonathan Legdon

COO

1,317,258

0p

2,174,699

Christopher Stone

Chair

585,500

1p

1,521,877

Phil Kelly

NED

N/A

N/A

105,263

 

Following this notification, the PDMRs no longer hold any beneficial holding in the Company.

Admission and Total Voting Rights

Following the acceptance of proposals relating to Idox shares in connection with the Offer and following the Offer becoming unconditional an application has been made for a total of 13,160,839 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 23 April 2026.

The total number of Ordinary Shares in issue following Admission will be 474,842,885. Therefore the total number of Ordinary Shares with voting rights in the Company will be 474,842,885.

The above figure of 474,842,885 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail in respect of the PDMRs:

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

David Meaden

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

1. Exercise of options over Ordinary Shares

2. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

1.

n/a

1,837,455

2.

71.5p

3,290,842

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

1.

n/a

1,837,455

2.

71.5p

3,290,842

e.

Date of the transaction

1. 22 April 2026

2. 22 April 2026

f.

Place of the transaction

1. Outside a trading venue

2. London Stock Exchange (XLON); AIM

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Anoop Kang

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

3. Exercise of options over Ordinary Shares

4. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

3.

n/a

1,440,477

4.

71.5p

1,458,699

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

3.

n/a

1,440,477

4.

71.5p

1,458,699

e.

Date of the transaction

3. 22 April 2026

4. 22 April 2026

f.

Place of the transaction

3. Outside a trading venue

4. London Stock Exchange (XLON); AIM

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Legdon

2.

Reason for the notification

a.

Position/status

Chief Operational Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

5. Exercise of options over Ordinary Shares

6. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

5.

n/a

1,317,258

6.

71.5p

2,174,969

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

5.

n/a

1,317,258

6.

71.5p

2,174,969

e.

Date of the transaction

5. 22 April 2026

6. 22 April 2026

f.

Place of the transaction

5. Outside a trading venue

6. London Stock Exchange (XLON); AIM

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Stone

2.

Reason for the notification

a.

Position/status

Non-executive chair and director

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

1. Exercise of options over Ordinary Shares

2. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

1.

n/a

585,500

2.

71.5p

1,521,877

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

1.

n/a

585,500

2.

71.5p

1,521,877

e.

Date of the transaction

1. 22 April 2026

2. 22 April 2026

f.

Place of the transaction

1. Outside a trading venue

2. London Stock Exchange (XLON); AIM

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Phil Kelly

2.

Reason for the notification

a.

Position/status

Non-executive director

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

71.5p

105,263

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

71.5p

105,263

e.

Date of the transaction

 22 April 2026

f.

Place of the transaction

London Stock Exchange (XLON); AIM

 

For further information please contact:

 

Idox plc

+44 (0) 333 011 1200

 

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com 

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Neil Patel

 

Benjamin Cryer

 

Kate Bannatyne

 

Alice Lane

 

MHP Group

+44 (0) 7885 447944

Reg Hoare

 idox@mhpgroup.com

Matthew Taylor

Finn Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZDMZVGVZM
Date   Source Headline
24th Apr 20184:32 pmRNSHolding(s) in Company
24th Apr 201810:24 amRNSHolding(s) in Company
23rd Apr 20183:40 pmRNSHolding(s) in Company
19th Apr 20183:58 pmRNSResult of AGM and Board Change
19th Apr 20183:54 pmRNSAGM Statement and Trading Update
19th Apr 20187:00 amRNSAGM Statement and Trading Update
27th Mar 20185:17 pmRNSDirector/PDMR Shareholding
27th Mar 201811:02 amRNSPosting of Annual Report and Notice of AGM
22nd Mar 20185:27 pmRNSHolding(s) in Company
19th Mar 201811:22 amRNSHolding(s) in Company
15th Mar 20185:17 pmRNSVesting of LTIP
8th Mar 20184:43 pmRNSHolding(s) in Company
1st Mar 201812:25 pmRNSDirectorate Change
1st Mar 201811:30 amRNSHolding(s) in Company
1st Mar 20187:00 amRNSFinal Results
20th Feb 201812:24 pmRNSHolding(s) in Company
2nd Feb 20184:12 pmRNSHolding(s) in Company
2nd Feb 20188:58 amRNSHolding(s) in Company
31st Jan 20184:52 pmRNSHolding(s) in Company
25th Jan 201812:34 pmRNSDirector/PDMR Shareholding
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
3rd Jan 201810:51 amRNSHolding(s) in Company
27th Dec 20171:48 pmRNSHolding(s) in Company
13th Dec 20177:00 amRNSYear End Update and Board Change
14th Nov 20173:45 pmRNSYear End Trading Update
2nd Nov 20171:31 pmRNSDirector Update
22nd Sep 20172:33 pmRNSExercise of Options and Total Voting Rights
20th Sep 20179:32 amRNSHolding(s) in Company
4th Sep 201710:38 amRNSDirectors' Dealing, Exercise of Options & TVR
1st Sep 20176:16 pmRNSHolding(s) in Company
23rd Aug 20176:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAcquisition
4th Aug 20174:20 pmRNSDirector and PCA Dealing
14th Jul 20173:52 pmRNSDirector/PDMR Shareholding
6th Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20175:23 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Jun 20177:00 amRNSHalf-year Report
18th May 20177:00 amRNSHalf Year Trading Update and Notice of Results
17th May 20174:31 pmRNSHolding(s) in Company
18th Apr 20173:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
7th Apr 20172:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20179:22 amRNSDirector and PCA Dealing
24th Feb 201712:53 pmRNSResult of AGM
24th Feb 20177:00 amRNSAGM Trading Update
15th Feb 20172:55 pmRNSHolding(s) in Company
14th Feb 20171:24 pmRNSExercise of Options and Total Voting Rights
10th Feb 20173:39 pmRNSDirector/PDMR Shareholding
6th Feb 20176:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20179:48 amRNSDirectors' Dealing, Exercise of Options and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.